The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF
Open accessAbstract
Aims: To date, clinical evidence of microvascular dysfunction in patients with heart failure (HF) with preserved ejection fraction (HFpEF) has been limited. We aimed to investigate the prevalence of coronary microvascular dysfunction (CMD) and its association with systemic endothelial dysfunction, HF severity, and myocardial dysfunction in a well defined, multi-centre HFpEF population. Methods and results: This prospective multinational multi-centre observational study enrolled patients fulfilling strict criteria for HFpEF according to current guidelines. Those with known unrevascularized macrovascular coronary artery disease (CAD) were excluded. Coronary flow reserve (CFR) was measured with adenosine stress transthoracic Doppler echocardiography. Systemic endothelial function [reactive hyperaemia index (RHI)] was measured by peripheral arterial tonometry. Among 202 patients with HFpEF, 151 [75% (95% confidence interval 69-81%)] had CMD (defined as CFR <2.5). Patients with CMD had a higher prevalence of current or prior smoking (70% vs. 43%; P = 0.0006) and atrial fibrillation (58% vs. 25%; P = 0.004) compared with those without CMD. Worse CFR was associated with higher urinary albumin-to-creatinine ratio (UACR) and NTproBNP, and lower RHI, tricuspid annular plane systolic excursion, and right ventricular (RV) free wall strain after adjustment for age, sex, body mass index, atrial fibrillation, diabetes, revascularized CAD, smoking, left ventricular mass, and study site (P < 0.05 for all associations). Conclusions: PROMIS-HFpEF is the first prospective multi-centre, multinational study to demonstrate a high prevalence of CMD in HFpEF in the absence of unrevascularized macrovascular CAD, and to show its association with systemic endothelial dysfunction (RHI, UACR) as well as markers of HF severity (NTproBNP and RV dysfunction). Microvascular dysfunction may be a promising therapeutic target in HFpEF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Obesity and diabetes create a pro-inflammatory state and promote endothelial and coronary microvascular dysfunction. 1,7,8”
From Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredIn the citing paper
“Inhibition of systemic metabolic inflammation with glucose-lowering drugs is thought to enhance endothelial and cardiomyocyte function”
From The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF (2023) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
Lang, R. M., Badano, L. P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., Flachskampf, F. A., Foster, E., Goldstein, S. A., Kuznetsova, T., et al. (2015) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.10.003 · Cited by 12,362
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Rudski, L., Lai, W. W., Afilalo, J., Hua, L., Handschumacher, M. D., Chandrasekaran, K., Solomon, S. D., Louie, E. K., & Schiller, N. B. (2010) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2010.05.010 · Cited by 7,080
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., Dokainish, H., Edvardsen, T., Flachskampf, F. A., Gillebert, T. C., Klein, A. L., Lancellotti, P., et al. (2016) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2016.01.011 · Cited by 5,262
2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
Nagueh, S. F., Appleton, C. P., Gillebert, T. C., Marino, P. N., Oh, J. K., Smiseth, O. A., Waggoner, A. D., Flachskampf, F. A., Pellikka, P. A., & Evangelista, A. (2009) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.11.023 · Cited by 4,367
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
Cited by
Sorted by citations
Items 301–400 of 656
Is heart failure with preserved ejection fraction a ‘dementia’ of the heart?
Tini, G., Cannata, A. N., Canepa, M., Masci, P. G., Pardini, M., Giacca, M., Sinagra, G., Marchionni, N., del Monte, F., Udelson, J. E., et al. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10114-9 · Cited by 13
Kwan, A. C., Demosthenes, E., Salto, G., Ouyang, D., Nguyen, T., Nwabuo, C. C., Luong, E., Hoang, A., Osypiuk, E. W., Stantchev, P., et al. (2022) · Heart · doi:10.1136/heartjnl-2022-320876 · Cited by 13
Physiologic Phenotyping of Responses to Exercise and Activity in Heart Failure
Lewis, G. D., Tada, A., Landsteiner, I., & Borlaug, B. A. (2025) · Circulation Research · doi:10.1161/circresaha.125.325534 · Cited by 15
Li, X., Sun, M., Wang, Z., Sun, S., & Wang, Y. (2023) · European Journal of Clinical Investigation · doi:10.1111/eci.14130 · Cited by 12
Göpel, S., Adingupu, D. D., Wang, J., Semenova, E., Behrendt, M., Jansson‐Löfmark, R., Ahlström, C., Jönsson‐Rylander, A., Gopaul, V. S., ESTERLINE, R. L., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02491-w · Cited by 13
Vascular remodelling in a mouse model of heart failure with preserved ejection fraction
Sanhueza‐Olivares, F., Valenzuela‐Arce, F., Calle, X., Silva, D., Muñoz‐Córdova, F., Mella‐Torres, A., Ortega, A., Troncoso, M. F., Muñoz-Rodríguez, C., la Fuente, F. P.-D., et al. (2025) · The Journal of Physiology · doi:10.1113/jp287094 · Cited by 12
Sweat the small stuff: The human microvasculature and heart disease
Katunaric, B., Cohen, K. E., Beyer, A., Gutterman, D. D., & Freed, J. K. (2020) · Microcirculation · doi:10.1111/micc.12658 · Cited by 13
Pugliese, N. R., Pieroni, A., Biase, N. D., Fiore, V., Nesti, L., Agostoni, P., & Dini, F. L. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10194-7 · Cited by 14
Sex differences and related estrogenic effects in heart failure with preserved ejection fraction
Deng, S., Lin, J., Zhao, Z., & Guanwei, F. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10274-2 · Cited by 13
Kashioulis, P., Guron, C. W., Svensson, M. K. E., Hammarsten, O., Saeed, A., & Guron, G. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12878 · Cited by 12
Prescott, E., Pernow, J., Saraste, A., Åkerblom, A., Angerås, O., Erlinge, D., Grove, E. L., Hedman, M., Jensen, L. O., Svedlund, S., et al. (2020) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2020.100629 · Cited by 12
A potential role of autophagy-mediated vascular senescence in the pathophysiology of HFpEF
Sanhueza‐Olivares, F., Troncoso, M. F., la Fuente, F. P.-D., Martinez-Bilbao, J., Riquelme, J. A., Norambuena‐Soto, I., Villa, M., Lavandero, S., Castro, P., & Chiong, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1057349 · Cited by 13
Taqueti, V. R. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2021.1832 · Cited by 12
Single-Cell Analysis of Human Heart Failure With Preserved Ejection Fraction
Hahn, V. S., Chaffin, M. D., Simonson, B., Jenkin, S. C., Mulligan, A. S., Rezaee, M., Bedi, K. C., Margulies, K. B., Klattenhoff, C., Sharma, K., et al. (2026) · Circulation Research · doi:10.1161/circresaha.125.327433 · Cited by 28
Matan, D., Mobarrez, F., Löfström, U., Corbascio, M., Ekström, M., Hage, C., Lyngå, P., Persson, B., Eriksson, M. J., Linde, C. M., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.952974 · Cited by 11
Sex-Specific Thresholds for Cardiac Biomarkers—We Need to Move Forward
Lobo, R., & Jaffe, A. S. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2403086 · Cited by 12
Liu, Q., Li, Q., Wan, X., Xu, M., Pan, J., Zhang, Y., Li, M., & Zhang, M. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1119785 · Cited by 11
Balestrieri, G., Limonta, R., Ponti, E., Merlo, A., Sciatti, E., D’Isa, S., Gori, M., Casu, G., Giannattasio, C., Senni, M., et al. (2024) · Cardiac failure review · doi:10.15420/cfr.2023.13 · Cited by 15
Coronary microvascular dysfunction beyond the spectrum of chronic coronary syndromes
Belmonte, M., Foà, A., Paolisso, P., Bergamaschi, L., Gallinoro, E., Polimeni, A., Scarsini, R., Muscoli, S., Amicone, S., Vita, A. D., et al. (2024) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2024.10.006 · Cited by 11
Focusing on microvascular function in heart failure with preserved ejection fraction
Velollari, O., Rommel, K., Kresoja, K., Lurz, P. C., & Gori, T. (2025) · Heart Failure Reviews · doi:10.1007/s10741-024-10479-7 · Cited by 12
Tenascin-C drives cardiovascular dysfunction in a mouse model of diabetic cardiomyopathy
Arnold, Z., Dostal, C., Szabó, P. L., Aykac, I., Goncalves, A. I. A., Sousa, S. L., Baydar, S., Budde, H., Váradi, B., Nádasy, G. L., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02780-y · Cited by 11
Aldiwani, H., Nelson, M. D., Sharif, B., Wei, J., Samuel, T. J., Suppogu, N. S., Quesada, O., Cook‐Wiens, G., Gill, E. B., Szczepaniak, L. S., et al. (2022) · Vessel Plus · doi:10.20517/2574-1209.2021.103 · Cited by 11
Singh, S., & Nappi, F. (2022) · Biomedicines · doi:10.3390/biomedicines10123010 · Cited by 11
Suppression of Tumourigenicity 2 in Heart Failure With Preserved Ejection Fraction
Zach, V., Baehr, F., & Edelmann, F. (2020) · Cardiac failure review · doi:10.15420/cfr.2019.10 · Cited by 12
Jimba, T., Kohsaka, S., Yamasaki, M., Otsuka, T., Harada, K., Shiraishi, Y., Koba, S., Takei, M., Kohno, T., Matsushita, K., et al. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14010 · Cited by 10
Radakrishnan, A., Agrawal, S., Singh, N., Barbieri, A., Shaw, L. J., Gulati, M., & Lala, A. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.100928 · Cited by 12
Li, H., Xia, Y., Xia, C., Li, Z., Shi, Y. P., Li, X., & Zhang, J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.879214 · Cited by 9
Strengths and weaknesses of alternative noninvasive imaging approaches for microvascular ischemia
Leo, I., Nakou, E. S., Artico, J., Androulakis, E., Wong, J. L., Moon, J., Indolfi, C., & Bucciarelli‐Ducci, C. (2022) · Journal of Nuclear Cardiology · doi:10.1007/s12350-022-03066-6 · Cited by 10
Erhardsson, M., Faxén, U. L., Venkateshvaran, A., Svedlund, S., Saraste, A., Fermer, M. L., Gan, L., Shah, S. J., Tromp, J., Lam, C. S. P., et al. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14569 · Cited by 9
Bortezomib induced pulmonary toxicity: a case report and review of the literature
Sağlam, B., Kalyon, H., Özbalak, M., Örnek, S., Keske, Ş., Tabak, L., Çakar, N., Zeren, H., Aytekin, S., Bölükbaşı, Y., et al. (2020) · Europe PMC (PubMed Central) · doi:10.5281/zenodo.4714766 · Cited by 9
Kim, S. R., Cho, D., Kim, M., & Park, S. (2021) · International Journal of Heart Failure · doi:10.36628/ijhf.2021.0029 · Cited by 9
Wang, D., Li, X., Feng, W. S., Zhou, H., Peng, W., & Wang, X. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1360648 · Cited by 12
Benenati, S., Campo, G. C., Seitun, S., Caglioni, S., Leone, A. M., & Porto, I. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.07.017 · Cited by 9
Zimmerli, A., Salihu, A., Antiochos, P., Lu, H. Y., Gros, B. P., Berger, A., Müller, O., Meier, D. J., & Fournier, S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030829 · Cited by 12
Popović, D., Reddy, Y. N. V., Omar, M., Omote, K., Melenovský, V., Burkhoff, D., & Borlaug, B. A. (2025) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2025.02.022 · Cited by 9
The myocardial flow reserve in patients with heart failure with preserved ejection fraction
Mochula, A. V., Kopeva, K. V., Maltseva, A. N., Grakova, E. V., Gulya, M. O., Сморгон, А. В., Гусакова, А. М., & Zavadovsky, K. V. (2022) · Heart and Vessels · doi:10.1007/s00380-022-02161-5 · Cited by 9
Key Phenotypes of Heart Failure with Preserved Ejection Fraction
Kagami, K., Harada, T., Ishii, H., & Obokata, M. (2022) · Cardiology Clinics · doi:10.1016/j.ccl.2022.06.001 · Cited by 9
Zeng, F., Zhou, P., Wang, M., Xie, L., Huang, X., Wang, Y., Huang, J., Shao, X., Yang, Y., Liu, W., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.111014 · Cited by 10
Fopiano, K. A., Jalnapurkar, S., Davila, A. C., Arora, V., & Bagi, Z. A. (2021) · Current Cardiology Reviews · doi:10.2174/1573403x17666210831144651 · Cited by 9
Coronary Microvascular Dysfunction in Patients with Congenital Heart Disease
Vanreusel, I., Segers, V. F. M., Craenenbroeck, E. M. V., & Berendoncks, A. V. (2023) · Current Cardiology Reviews · doi:10.2174/1573403x19666230119112634 · Cited by 8
Bennett, J. B., van Dinther, M., Voorter, P., Backes, W. H., Barnes, J., Barkhof, F., Captur, G., Hughes, A. D., Sudre, C. H., & Treibel, T. A. (2023) · Medicina · doi:10.3390/medicina59091596 · Cited by 9
Coronary Microvascular Dysfunction and Left Heart Filling Pressures in Patients with Type 2 Diabetes
Wolsk, E., Jürgens, M., Schou, M., Ersbøll, M. K., Hasbak, P., Kjær, A., Zerahn, B., Brandt, N., Gæde, P., Rossing, P. R., et al. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14929 · Cited by 7
Soulié, M., Stéphan, Y., Durand, M., Lima‐Posada, I., Palacios, R., Nicol, L., López‐Andrés, N., Mulder, P. G. H., & Jaisser, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-74934-z · Cited by 9
Neuro-immune interactions in coronary microvascular disease: mechanisms and therapeutic prospect
Zhao, G., Wu, G., Ma, J., Ren, S., Liu, T., Wu, X., & Wang, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1631083 · Cited by 8
Zhou, Y., Yan, H., Zhu, Y., Jiang, W., & Zhang, S. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1701459 · Cited by 8
Bellicini, M. G. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004283 · Cited by 9
Kelly, S. C., Rau, C. D., Ouyang, A., Thorne, P. K., Olver, T. D., Edwards, J. C., Domeier, T. L., Padilla, J., Grisanti, L. A., Fleenor, B. S., et al. (2021) · Physiological Genomics · doi:10.1152/physiolgenomics.00093.2020 · Cited by 8
Punta, L. D., Biase, N. D., Balletti, A., Filidei, F., Pieroni, A., Armenia, S., Mengozzi, A., Mazzola, M., Fiore, V. D., Dini, F. L., et al. (2022) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-021-00494-2 · Cited by 8
Principles for diagnosing heart failure with preserved ejection fraction
Евгеньевич, Ш. Н., Yaroslavskaya, E. I., Криночкин, Д. В., Musikhina, N. A., Gizatulina, T. P., Enina, T. N., Petelina, T. I., Soldatova, A. M., Samoilova, E. P., Pogorelov, N. O., et al. (2023) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2023-5448 · Cited by 8
Imaging and mechanisms of heart failure with preserved ejection fraction: a state-of-the-art review
Harada, T., Tada, A., & Borlaug, B. A. (2024) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeae152 · Cited by 10
Fopiano, K. A., Zhazykbayeva, S., El‐Battrawy, I., Buncha, V., Pearson, W. M., Hardell, D. J., Lang, L., Hamdani, N., & Bagi, Z. A. (2024) · Microcirculation · doi:10.1111/micc.12888 · Cited by 8
Yoshida, Y., Nakanishi, K., Daimon, M., Ishiwata, J., Sawada, N., Hirokawa, M., Kaneko, H., Nakao, T., Mizuno, Y., Morita, H., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021624 · Cited by 8
Chi, K., Yang, S., Zhang, Y., Zhao, Y., Zhao, J., Chen, Q., Ge, Y., & Liu, J. (2024) · Medicine · doi:10.1097/md.0000000000037727 · Cited by 7
Mourmans, S. G. J., Achten, A., Hermans, R., Scheepers, M. J. E., D’Alessandro, E., Swennen, G., Woudstra, J., Appelman, Y., van Goor, H., Schalkwijk, C. G., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02679-8 · Cited by 7
Cardiac positron emission tomography/Computed tomography (PET/CT) in current cardiology guidelines
Alwan, M., Yaman, A. E., Sayed, A., Shaikh, A., Rifai, M. A., & Al-Mallah, M. H. (2025) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2025.102231 · Cited by 7
Examining the Disproportionate Burden of Microvascular Disease in Women
O'Hara, M., Roy, R., Altenburg, M., Slivnick, J. A., & Patel, H. N. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01310-1 · Cited by 7
Weerts, J., Schroen, B. L. M., Aizpurua, A. B., Berendschot, T. T. J. M., Brandts, L., Webers, C. A. B., Simons, S. O., Meex, S. J. R., Henry, R. M. A., Kallen, C., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02850-1 · Cited by 7
Pagnesi, M., Riccardi, M., Maisano, F., Grapsa, J., Barberis, V. I., Abdelhamid, M., Antohi, E., Arfsten, H., Karam, N., Muraru, D., et al. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15405 · Cited by 9
Lv, L., Ma, X., Xu, Y., Zhang, Q., Kan, S., Chen, X., Liu, H., Wang, H., Wang, C., & Ma, J. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02809-0 · Cited by 7
Guo, X., Zhai, Y., Song, C., Mi, Z., Peng, J., Guo, J., Teng, X., & Zhang, D. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01820-4 · Cited by 7
Wang, Q., Xu, C., He, Z., Zou, P., Yang, J., & Huang, Y. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292285 · Cited by 7
Clinical aspects of ischemia with no obstructive coronary artery disease (INOCA)
Polyak, A., Wei, J., Gulati, M., & Merz, C. N. B. (2023) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2023.100352 · Cited by 7
Coronary microvascular dysfunction and atrial reservoir function
Mela, J. L., Riou, L. M., & Barone‐Rochette, G. (2024) · Cardiovascular Ultrasound · doi:10.1186/s12947-024-00324-0 · Cited by 8
Östlund-Papadogeorgos, N., Ekenbäck, C., Jokhaji, F., Mir-Akbari, H., Witt, N., Jernberg, T., Wallén, H., Linder, R. B. A., Törnerud, M., Samad, B. A., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.05.037 · Cited by 8
Sušić, L., Maričić, L., Vincelj, J., Vadoci, M., & Sušić, T. (2021) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v92i3.11495 · Cited by 7
Coronary flow reserve in patients with heart failure with preserved ejection fraction
Mochula, A. V., Kopeva, K. V., Maltseva, A. N., Grakova, E. V., Gulya, M. O., Гусакова, А. М., & Zavadovsky, K. V. (2022) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2022-4743 · Cited by 8
Tune, J. D., Goodwill, A. G., Baker, H. E., Dick, G. M., Warne, C. M., Tucker, S. M., Essajee, S. I., Bailey, C. A., Klasing, J. A., Russell, J. J., et al. (2022) · Basic Research in Cardiology · doi:10.1007/s00395-022-00958-z · Cited by 7
Azuma, M., Kato, S., Fukui, K., Horita, N., & Utsunomiya, D. (2023) · Microcirculation · doi:10.1111/micc.12822 · Cited by 7
Clinical Features of Heart Failure With Normal Ejection Fraction
TERAMOTO, K., Ouwerkerk, W., Tay, W. T., Tromp, J., Teng, T. K., Chandramouli, C., Fermer, M. L., Hung, C., Anand, I. S., Solomon, S. D., et al. (2023) · JACC Asia · doi:10.1016/j.jacasi.2023.06.007 · Cited by 7
Angulo, J., Fernández, A., Sevilleja-Ortiz, A., Sánchez‐Ferrer, A., Rodríguez‐Mañas, L., & Assar, M. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713402 · Cited by 7
Basu, S., Yu, H., Murrow, J. R., & Hallow, K. M. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011598 · Cited by 7
Luo, W., Guo, Y., Huang, J., & Zhang, P. (2019) · BioMed Research International · doi:10.1155/2019/4069097 · Cited by 7
Hung, T., Chien, S., Tsao, C., Wu, Y., Yen, C., Hsiao, C., Lin, H., Tsai, J., Peng, M., Tsai, C., et al. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133064 · Cited by 6
Effect of sodium-glucose Co-transporter 2 inhibitors on coronary microcirculation
Chen, S., Ou, W., Gan, S., Chen, L., Liu, B., & Zhang, Z. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1523727 · Cited by 7
Ono, R., & Falcão, L. M. (2025) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2025.02.007 · Cited by 6
Coronary Microvascular Dysfunction in Ischaemic Heart Disease: Lessons From Large Animal Models
Sorop, O., van de Wouw, J., Merkus, D., & Duncker, D. J. (2025) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70074 · Cited by 7
Exploring coronary microvascular dysfunction from functional impairment and structural damage
Wen, W., Zhang, Y., Jia, G., & Chi, Y. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1600947 · Cited by 6
Li, Y., Sun, D., Zhao, H., Qin, Z., Ji, W., Zhang, H., Jiao, N., Luan, B., Ding, M., & Zhu, F. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1209122 · Cited by 6
Kim, S. R., Kim, M., Cho, D., Kim, H., Bae, S. A., Kim, H., Kim, M., Hong, K.-S., Shim, W. J., & Park, S. (2023) · Clinical Research in Cardiology · doi:10.1007/s00392-023-02358-2 · Cited by 6
Stress Echocardiography for Assessment of Diastolic Function
Laws, J. L., Maya, T. R., & Gupta, D. K. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02142-2 · Cited by 6
Coronary Microvascular Dysfunction
Carli, M. F. D. (2025) · Heart Failure Clinics · doi:10.1016/j.hfc.2025.01.002 · Cited by 7
Katsura, M., Horiuchi, Y., Yoshiura, D., Yahagi, K., Gonda, Y., Asami, M., Taniwaki, M., Komiyama, K., Yuzawa, H., Tanaka, J., et al. (2025) · Heart and Vessels · doi:10.1007/s00380-025-02576-w · Cited by 6
Quesada, O., Elboudwarej, O., Nelson, M. D., AlBadri, A., Mastali, M., Wei, J., Zarrabi, B., Suppogu, N. S., Aldiwani, H., Mehta, P. K., et al. (2022) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2022.100115 · Cited by 6
Tochiya, M., Makino, H., Tamanaha, T., Omura‐Ohata, Y., Matsubara, M., Koezuka, R., Noguchi, M., Tomita, T., Asaumi, Y., Miyamoto, Y., et al. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14280 · Cited by 6
Anxiety is associated with coronary microvascular dysfunction: Results from the CAMADA study
Li, Y., Xu, W., & Guo, L. (2023) · Microcirculation · doi:10.1111/micc.12798 · Cited by 6
Development and Challenges of Pre-Heart Failure with Preserved Ejection Fraction
Dong, G. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2409274 · Cited by 8
Risk Factors and Cellular Differences in Heart Failure: The Key Role of Sex Hormones
Delcuratolo, E., Palazzuoli, A., Coppi, F., Mattioli, A. V., Severino, P., Tramonte, F., & Fedele, F. G. (2023) · Biomedicines · doi:10.3390/biomedicines11113052 · Cited by 6
Kong, H., Cao, J., Tian, J., Ji, Y., An, J., Zhang, L., Song, X., & He, Y. (2024) · Clinical Radiology · doi:10.1016/j.crad.2024.01.010 · Cited by 6
Aging and Heart Failure with Preserved Ejection Fraction
Larson, K. F., Malik, A., & Brozovich, F. V. (2022) · Comprehensive physiology · doi:10.1002/cphy.c210035 · Cited by 12
Left Ventricular Diastolic Dysfunction: Diagnostic and Prognostic Perspectives
Nagueh, S. F. (2022) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2022.12.015 · Cited by 6
Candreva, A., & Templin, C. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad264 · Cited by 6
Saadati, N., Masihi, S., Abouali, N., Akiash, N., Jafari, R. M., & Tahmasebi, Y. (2024) · Journal Of Advanced Pharmacy Education And Research · doi:10.51847/qvxattlhkc · Cited by 5
The Key Role of Diagnostic Imaging in Early HFpEF
Yaku, H., & Shah, S. J. (2025) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2025.05.016 · Cited by 7
Prognostic Role of Dynamic CZT Imaging in Heart Failure With Preserved Ejection Fraction
Kopeva, K. V., Mochula, A. V., Maltseva, A. N., Soldenko, M. V., Grakova, E. V., & Zavadovsky, K. V. (2023) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000004738 · Cited by 5
Hirose, K., Nakanishi, K., Tullio, M. R. D., Homma, S., Sawada, N., Yoshida, Y., Hirokawa, M., Koyama, K., Kimura, K., Nakao, T., et al. (2023) · European Heart Journal Open · doi:10.1093/ehjopen/oead108 · Cited by 5
Li, Y., Wang, C., Hung, C., Wu, Y., Hsu, C., Tsou, Y., Wang, C., Wu, C., Lin, P., Chang, H., et al. (2024) · PubMed Central · doi:10.6515/acs.202403_40(2).20240206a · Cited by 5
Dimitriadis, K. S., Theofilis, P., Koutsopoulos, G., Pyrpyris, N., Beneki, E., Tatakis, F., Tsioufis, P., Chrysohoou, C. A., Fragkoulis, C., & Tsioufis, K. P. (2024) · Heart Failure Reviews · doi:10.1007/s10741-024-10445-3 · Cited by 6
Promoting Resiliency to Stress in the Vascular Endothelium
Jaramillo-Torres, M. J., Limpert, R., Butak, W., Cohen, K. E., Whitaker, A. A., SenthilKumar, G., Durand, M. J., & Freed, J. K. (2025) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70001 · Cited by 7
Every Now and Then I Fall Apart
Jain, C. C., Egbe, A. C., & Borlaug, B. A. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.007145 · Cited by 5
Sciatti, E., Mohseni, Z., Orabona, R., Mulder, E., Prefumo, F., Lorusso, R., Frusca, T., Ghossein‐Doha, C., & Spaanderman, M. E. A. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002901 · Cited by 5
Metadata
- Authors
- Shah, S. J., Lam, C. S. P., Svedlund, S., Saraste, A., Hage, C., Tan, R.-S., Beussink-Nelson, L., Ljung Faxén, U., Fermer, M. L., Broberg, M. A., Gan, L.-M., & Lund, L. H.
- Affiliations
- Northwestern University (US)
- University Medical Center Groningen (NL)
- Sahlgrenska University Hospital (SE)
- University of Turku (FI)
- Karolinska Institutet (SE)
- National University of Singapore (SG)
- Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
- Department of Medicine, Cardiology Unit and Heart and Vascular Theme, Karolinska Institutet, Stockholm, Sweden
- Early Clinical Development, IMED Biotech Unit, AstraZeneca Gothenburg, Sweden
- AstraZeneca (Sweden) (SE)
- Corresponding author
- Gan, Li-Ming
- Lund, Lars H
- ORCID
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-08-27
- Volume
- 39
- Issue
- 37
- Pages
- 3439-3450
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- PMC
- PMC6927847
- OpenAlex
- W2889002990
- Cited by
- 656
- References
- 45
- Citations by year
- 2026: 79 · 2025: 91 · 2024: 100 · 2023: 98 · 2022: 93 · 2021: 73 · 2020: 67 · 2019: 48 · 2018: 5
- FWCI
- 36.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- European Heart Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Funders
- NIH
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- heart failure with preserved ejection fraction, coronary microvascular dysfunction, coronary flow reserve, endothelial dysfunction, reactive hyperaemia index, albumin-creatinine ratio, NT-proBNP, right ventricular dysfunction, atrial fibrillation, smoking, prevalence
- MeSH terms
- Aged, Aged, 80 and over, Coronary Vessels, Female, Humans, Male, Middle Aged, Prospective Studies, Echocardiography, Doppler, Heart Failure, Diastolic, Microvessels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
